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Background: COVID-19 has impacted acute stroke care with several reports showing
worldwide drops in stroke caseload during the pandemic. We studied the impact of
COVID-19 on acute stroke care in our health system serving Southeast Michigan as
we rolled out a policy to limit admissions and transfers.Methods: in this retrospective
study conducted at two stroke centers, we included consecutive patients presenting
to the ED for whom a stroke alert was activated during the period extending from 3/
20/20 to 5/20/20 and a similar period in 2019. We compared demographics, time
metrics, and discharge outcomes between the two groups. Results: of 385 patients pre-
sented to the ED during the two time periods, 58% were African American. There
was a significant decrease in the number of stroke patients presenting to the ED and
admitted to the hospital between the two periods (p <0.001). In 2020, patients had
higher presenting NIHSS (median: 2 vs 5, p = 0.012), discharge NIHSS (median: 2 vs
3, p = 0.004), and longer times from LKW to ED arrival (4.8 vs 9.4 h, p = 0.031) and
stroke team activation (median: 10 vs 15 min, p = 0.006). In 2020, stroke mimics rates
were lower among African Americans. There were fewer hospitalizations (p <0.001),
and transfers from outside facilities (p = 0.015). Conclusion: a trend toward faster
stroke care in the ED was observed during the pandemic along with dramatically
reduced numbers of ED visits, hospitalizations and stroke mimics. Delayed ED pre-
sentations and higher stroke severity characterized the African American population,
highlighting deepening of racial disparities during the pandemic.
Key Words: COVID—Metrics—Racial disparities—Outcomes—Race—Ethnicity—
Stroke volume
© 2021 Elsevier Inc. All rights reserved.
Abbreviations: COVID19, Coronavirus Disease 2019; AA, African American; SA, stroke alert; HCP, health care providers; AS, acute stroke; AST,
acute stroke team; AIS, acute ischemic stroke; TIA, Transient ischemic attack; ED, emergency department; IVT, Intravenous thrombolysis; MT,
mechanical thrombectomy; LKW, last known well; STA, stoke team activation; NIHSS, National Institute of health stroke scale; ICH, intracerebral
hemorrhage; SAH, subarachnoid hemorrhage; EMS, emergency medical service; AMA, against medical advice; LWCS, left without completion of
service; CAD, coronary artery disease; MI, myocardial infarction; PVD, peripheral vascular disease; DVT, deep vein thrombosis; PE, pulmonary
embolism; CTA, computed tomography angiogram; DSA, digital subtraction angiography; MRA, magnetic resonance angiogram
From the *Department of Neurology, Henry Ford Hospital, Detroit, MI, United States; †School of Medicine, Wayne State University, Detroit, MI,
United States; ‡Public Health Sciences, Henry Ford Hospital, Detroit, MI, United States; §Comprehensive Stroke Center, Henry Ford Health Sys-
tem, Detroit, MI, United States; and {Department of Neurology, University of Minnesota, Minneapolis, MN, United States.
Received November 9, 2020; revision received March 1, 2021; accepted March 7, 2021.
Corresponding author. E-mail: haboul1@hfhs.org.
1052-3057/$ - see front matter
© 2021 Elsevier Inc. All rights reserved.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105746
Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 6 (June), 2021: 105746 1
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by 
Elsevier on April 23, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Introduction
The Severe Acute Respiratory Syndrome Coronavi-
rus 2 (SARS-CoV2) pandemic has had drastic social,
economic, and public health repercussions world-
wide.1 At the various peaks of the pandemic around
the world, hospitals ran short on personnel, medical
supplies, protective personal equipment (PPE), inten-
sive care unit and general floor beds, and ventilators,
shunting most of the resources towards the care of
patients suspected or confirmed to have Coronavirus
Disease 2019 (COVID-19). As such, medical centers
have developed and rolled out various emergency pro-
tocols aimed at optimizing resource utilization by
guiding the triaging and management of acute medical
conditions to protect patients and healthcare providers
(HCP) from exposure and accommodate the sudden
surge in COVID-19 patient volumes.2 Beds have been
turned into isolation rooms, HCP of various specialties
have been deployed to cover COVID-19 units, diagnos-
tics and imaging modalities have been restricted to the
bare essentials, and most outpatients services have
migrated to virtual platforms.3 The care of acute medi-
cal conditions requiring urgent evaluation and man-
agement, such as acute ischemic strokes (AIS) and
transient ischemic attacks (TIA), has consequently
been impacted.
In fact, many reports from around the world point at a
reduction in the caseload of strokes presenting to the
emergency department (ED) and admitted to the hospital.
Intravenous thrombolysis (IVT) and mechanical throm-
bectomy (MT) therapies have decreased by 1860% com-
pared to the same period a year ago, based on reports
emanating from China, Italy, and Spain.4,5 Notably,
patients have been presenting later and with worse stroke
severity indices, mostly concerned about their risk of get-
ting exposed to the virus within the hospital environ-
ment.6-8 Fear of contracting the disease, enforcement of
social distancing measures and quarantines may have
contributed to stroke symptoms being discovered late,
reducing the usability of time-sensitive therapies.9
Anecdotally, these factors appear to have dispropor-
tionately impacted minorities and in particular African
Americans (AAs). Reports that came early in the pan-
demic alerted to AAs being at risk of more severe dis-
ease after contracting COVID-19. Nonetheless, thus
far, there is only a scant account of the differential
impact the COVID-19 pandemic has had on the care of
AIS and TIA among AAs and non-AAs.
In this study, we aim to showcase our experience with
ED stroke alerts and inpatient stroke admissions, compar-
ing a time period before (referred to as 2019) and a time
period during (referred to as 2020) the pandemic in a com-
prehensive stroke and thrombectomy capable centers of a
large tertiary health system in southeast Michigan, and
serving a large AA population.
Methods
Study setting
This is a retrospective study conducted at two teaching
hospitals within Henry Ford Health System (HFHS) serv-
ing southeast Michigan. Henry Ford Hospital (HFH) is a
designated comprehensive stroke center located in Detroit
(Wayne County) and Henry Ford West Bloomfield
(HFWB) is a Joint Commission-certified thrombectomy-
capable center in West Bloomfield (Oakland County).
Both hospitals share the same acute stroke management
pathways and are covered by common stroke and neuro-
interventional teams.
Acute stroke activation process
The acute stroke team (AST) is a multidisciplinary team
composed of vascular neurology and neuro-interventional
faculty and fellows, neurology residents, rapid response
nursing team, nursing staff and pharmacists. The AST is
available on call 24/7. A Stroke Alert (SA) is activated if
symptom onset or time of last known well (LKW) is within
24 h of presentation to a HFHS ED or hospital.
The interventional and vascular neurology teams were
of the same composition during the two time periods.
Study population and timeline
This study was approved by the HFHS Institutional
Review Board. Our prospectively collected data from the
Get With The Guidelines database as well as our SA logs
were mined for eligible patients. We analyzed two cohorts
of patients. The first cohort was consecutive patients pre-
senting to the EDs of HFH and HFWB on whom a SA was
activated from 3/20/2020 to 5/20/2020 (COVID period,
or “2020”) and the same epoch in 2019 (pre-COVID
period, or “2019”) for comparison. 3/20/2020 corre-
sponds to the date the amended HFHS tier 1 policy on
Emergency Care and Admissions of patients with AIS
and TIA went into effect system-wide to address resource
use optimization and exposure risk reduction during the
pandemic. The second cohort included patients who were
admitted to our stroke units from HFHS EDs or directly
transferred from outside hospitals or EDs with a diagnosis
of AIS, TIA, intracerebral hemorrhage (ICH) or subarach-
noid hemorrhage (SAH).
Clinical and demographic variables
The following demographic and clinical variables were
abstracted from review of electronic records. Demographic
variables: age, sex, race, ethnicity. Vascular risk factors:
hypertension, diabetes, hyperlipidemia, atrial fibrillation/
atrial flutter, tobacco smoking, coronary artery disease,
peripheral artery disease, history of strokes/TIA, heart fail-
ure and substance abuse. Clinical variables: mode of arrival
to initial ED, initial and discharge NIHSS, discharge after
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hospitalization modified Rankin score (mRS), COVID-19
status of patient (negative or positive/suspected), received
IVT, received MT, final diagnosis of stroke or stroke
mimics (seizures, conversion disorder, toxic and metabolic
disorders), stroke etiology based on the TOAST classifica-
tion criteria,10 and final disposition.
Time metrics for all patients
The following time metrics were collected for all
patients: LKW date/time, ED arrival date/time (door
time), door-to-physician contact time, door-to-stroke team
activation (STA) date/times, door-to-first brain imaging
time, and door-to-discharge time for patients discharged
from the ED and from the hospital for admitted patients.
Additional time metrics for IVT
LKW-to-needle time and door-to-needle (DTN) time.
Additional time metrics for MT
Door-to-arterial puncture time.
Statistical methods
For the categorical and binary variables, the number and
percentages were presented. For age, the mean and standard
deviation were presented. For the presenting NIHSS and
time variables, the median and interquartile range were pre-
sented. All variables were compared between 2019 and 2020
using univariate Wilcoxon rank-sum tests for continuous and
ordinal variables and using Fisher’s exact tests for categorical
variables. To test whether the number of ED patients or inpa-
tient admissions were similar between the 2019 and 2020
time periods a binomial test was done with a null hypothesis
of 50/50 split between the two years. The above analyses
were done for all patients and then for AAs and non-AAs
separately. Patients with unknown race were not included in
the analyses by race. Two-way analysis of variance (ANOVA)
were done for the continuous variables to test whether the
differences between 2019 and 2020 were similar for AAs and
non-AAs. For the time variables, log (x+1) transformations
were used in the ANOVA to reduce the impact of outliers. In
addition, multiple linear or ordinal logistic regression analy-
ses were done to adjust for patient demographics and hospi-
tal for select outcomes in the ED cohort and to adjust for
patient demographics, hospital and NIHSS at admission for
select outcomes in the inpatient admission cohort. The testing
level for all comparisons was 0.05. All analyses are performed
using SAS 9.4 (SAS Institute Inc, Cary, NC, USA).
Results
ED visits
All patients: There were a total of 394 ED visits for 385
patients. Seven patients had two ED visits during these
time intervals and one person had three visits. For the fol-
lowing analysis, only the first ED visits were included. For
the 385 patients, the mean age was 64 years (s.d.=15.5)
with a range from 20 to 97. Two hundred and two (52%)
were males, 224 (58%) were AAs, 128 (33%) were Cauca-
sian, 17 (4%) were other races and 16 (4%) had unknown/
not documented race. In 2019; 264 (69%) patients were
seen and 121 (31%) in 2020. The decrease in the number of
patients seen between 2019 and 2020 was significant
(p <0.001) (Fig.1A). The reduction between 2019 and 2020
was 54%, which was 10% larger than the reduction in all
ED visits during the same time periods (2019: 24,729 visits
vs 2020: 13,779, 44% reduction). The patients seen in 2020
had significantly higher presenting NIHSS when compared
to the 2019 patients (median: 5 vs 2, p = 0.012). They also
had significantly longer times since LKW to ED arrival
(median: 9.4 vs 4.8 h, p = 0.031). For the patients with STA
times available, the 2020 patients had significantly lower
times from arrival to STA (median: 10 vs 15 min, p=0.006).
This difference remained significant after adjusting for age,
gender, race and hospital (p = 0.026). They also had signifi-
cantly lower times from arrival to brain imaging (median:
26 vs 35 min, p = 0.042). However, after adjusting for age,
gender, race and hospital this difference was no longer sig-
nificant (p =0.676). The difference in final diagnosis was sig-
nificant between the two groups of patients (p <0.001),
with the 2020 patients having higher rates of AIS/TIA and
ICH/SAH and lower rates of stroke mimics compared to
the 2019 patients (Table 1).
AA patients: AA patients seen in 2020 had significantly
higher presenting NIHSS when compared to 2019
(median: 5 vs 3, p =0.004). They also had significantly lon-
ger times since LKW to ED arrival (median: 10.4 vs 5.2 h,
p=0.038). For the AA patients with STA times available,
the 2020 patients had significantly lower times from
arrival to STA (median: 10 vs 15 min, p =0.035). The differ-
ence in final diagnosis was significant between the two
years (p <0.001), with the 2020 patients having higher
rates of AIS/TIA and ICH/SAH and lower rates of stroke
mimics compared to the 2019 AA patients (Table 1).
Non-AA patients: Although it did not reach statistical
significance, the difference in final diagnosis did show a
trend similar to the AA patients with a higher rate of
AIS/TIA and a lower rate of stroke mimics in 2020
(p =0.065) (Table 1).
For all time variables as well as NIHSS, the differences
between 2019 and 2020 for the AA and non-AA patients
were not significant (p>0.07 for all).
Inpatient admissions
All patients: There were a total of 336 inpatient admis-
sions for 327 patients. Nine patients had two admissions
during these time intervals. For the following analysis,
only the first admissions were included. For the 327
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patients, the mean age was 66.2 (s.d.=14.1) with a range
from 27 to 97, 186 (57%) were males, 167 (51%) were AAs,
148 (45%) were Caucasian, 9 (3%) were other race and 3
(1%) had unknown/not documented race, and 219 (67%)
were seen in 2019 and 108 (33%) in 2020. The decrease in
the number of patients seen between 2019 and 2020 was
significant (p<0.001) (Fig. 1B). The racial distribution
between the two years differed with a significantly higher
rate of AAs seen in 2020 compared to 2019 (62% vs 47%,
p =0.012). The difference between the two years for the
Fig. 1. A: Weekly trends of ED visits comparing 2019 to 2020. B: Weekly trends of inpatient admissions comparing 2019 to 2020. C: Comparison between trans-
fer rates to HFH and HFWB from HFHS freestanding EDs, HFHS Hospitals EDs and outside hospitals.
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Table 1. Comparing 2019 to 2020 for ED visits.
Variable Response Total African American Non-African American
2019 (N= 264) 2020 (N= 121) p-value 2019 (N= 154) 2020 (N= 70) p-value 2019 (N= 102) 2020 (N= 43) p-value













Gender Female 129 (49%) 54 (45%) 0.444 80 (52%) 31 (44%) 0.315 44 (43%) 18 (42%) >.99
Male 135 (51%) 67 (55%) 74 (48%) 39 (56%) 58 (57%) 25 (58%)
Race African American 154 (58%) 70 (58%) 0.133
Caucasian 87 (33%) 41 (34%)
Other 15 (6%) 2 (2%)
Unknown 8 (3%) 8 (6%)
African American Yes 154 (60%) 70 (62%) 0.817
No 102 (40%) 43 (38%)
Hospital HFHMC 214 (81%) 89 (74%) 0.108 139 (90%) 63 (90%) >.99 67 (66%) 19 (44%) 0.026
WBH 50 (19%) 32 (26%) 15 (10%) 7 (10%) 35 (34%) 24 (56%)
NIHSS at
Admission





















N Median (IQR) 120 15 (10, 25) 38 10 (6, 19) 0.0061 80 15
(10, 25.5)























N Median (IQR) 42 6.9
(4.7, 9)







ED Disposition Left AMA/LWCS 4 (2%) 0 (0%) 0.448 2 (1%) 0 (0%) 0.639 1 (1%) 0 (0%) 0.488
Admit 217 (82%) 106 (88%) 126 (82%) 62 (89%) 86 (84%) 40 (93%)
Discharge 42 (16%) 15 (12%) 25 (16%) 8 (11%) 15 (15%) 3 (7%)
Transfer to Another
Facility
1 (0%) 0 (0%) 1 (1%) 0 (0%)
Final Diagnosis ICH/SAH 23 (9%) 17 (14%) <.001 11 (7%) 15 (21%) <.001 11 (11%) 2 (5%) 0.065
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method of arrival was significant (p<0.001) with more
2020 patients directly transported by EMS to our EDs
(51% vs 28%, p<0.001) and fewer transferred from other
hospitals (28% vs 42%, p =0.015) (Fig. 1C). The patients
seen in 2020 had significantly higher presenting NIHSS
when compared to the 2019 patients (median: 5 vs 3,
p =0.002). For the patients with times available, the shift
toward shorter times for the 2020 patients was significant
for times to STA (median: 8 vs 14 min, p =0.049). Patients
with ischemic strokes or TIAs admitted in 2020 had signif-
icantly higher NIHSS on discharge (median: 3 vs 2,
p =0.004) (Table 2).
AA patients: Patients seen in 2020 had higher NIHSS at
admission compared to patients seen in 2019 (median:
5 vs 3, p =0.005). They also had higher rates of ICH/SAH
(27% vs 12%, p =0.014). For patients with STA, patients
seen in 2020 had short times from arrival to STA (median:
8 vs 14.5 min, p =0.02). Patients seen in 2020 had higher
NIHSS at discharge (median: 3.5 vs 1, p<0.001) (Table 2).
Non-AA patients: Patients seen in 2020 were more
likely to have been seen first in the ED (80% vs 62%,
p =0.035) and had higher rates of EMS for the method
of arrival (44% vs 18%, p =0.002) and lower rates of
transfer from other hospitals (39% vs 57%, p =0.047).
For patients with available time information for ED
physician assessment, patients seen in 2020 had
shorter times from arrival to physician assessment
(median: 6.5 vs 13.5 min, p =0.015). Patients seen in
2020 with AIS/TIA had a higher rate of death com-
pared to patients seen in 2019 (12% vs 1%, p =0.015)
(Table 2).
For all time variables as well as NIHSS, the differences
between 2019 and 2020 for the AA and non-AA patients
were not significant (p>0.29 for all).
Intervention group
IVT: For all patients receiving IVT, there were no differ-
ences detected between the two years for IVT administra-
tion rates, reasons for not receiving IVT, and times
between LKW and IVT initiation. There was, however, a
trend toward shorter times from ED arrival to IVT initia-
tion in 2020 compared to 2019 (median: 38 vs 51 min,
p =0.051) (Table 3).
In AAs, there was a significant shift toward shorter times
from ED arrival to IVT initiation in 2020 compared to 2019
(median: 38 vs 58.5 min, p =0.029). In the non-AA patients,
patients seen in 2020 had higher IVT administration rates
at HFH (23% vs 7%, p =0.048), as well as at any hospital
facility (35% vs 13%, p =0.019) (Table 3).
MT: For all patients, no differences were detected between
the patients seen in 2019 and 2020 for MT rates, reasons for
not receiving MT, and time from arrival to arterial puncture
(Table 3). The same was true for AA patients. For the non-
AA patients, there was a trend toward higher MT rates in























































































































































































































































































































































































































































































































































6 H. ABOUL NOUR ET AL.
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by 
Elsevier on April 23, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Table 2. Comparing 2019 vs 2020  inpatient.
Variable Response Total African American Non-African American
2019 (N= 219) 2020 (N= 108) p-value 2019 (N= 101) 2020 (N= 66) p-value 2019 (N= 116) 2020 (N= 41) p-value
Demographic information













Gender Female 94 (43%) 47 (44%) >.99 51 (50%) 27 (41%) 0.268 42 (36%) 20 (49%) 0.194
Male 125 (57%) 61 (56%) 50 (50%) 39 (59%) 74 (64%) 21 (51%)
Race African American 101 (46%) 66 (61%) 0.011
Caucasian 107 (49%) 41 (38%)
Other 9 (4%) 0 (0%)
Unknown 2 (1%) 1 (1%)
African American Yes 101 (47%) 66 (62%) 0.012
No 116 (54%) 41 (38%)
Campus HFHMC 177 (81%) 81 (75%) 0.250 90 (89%) 59 (89%) >.99 85 (73%) 22 (54%) 0.031
WBH 42 (19%) 27 (25%) 11 (11%) 7 (11%) 31 (27%) 19 (46%)
Insurance type Medicare plus others 137 (63%) 68 (63%) 0.982 59 (58%) 41 (62%) 0.864 77 (66%) 27 (66%) 0.852
Private 37 (17%) 17 (16%) 13 (13%) 8 (12%) 23 (20%) 8 (20%)
Medicaid only 42 (19%) 22 (20%) 27 (27%) 17 (26%) 15 (13%) 5 (12%)




34 (16%) 9 (8%) 0.082 11 (11%) 4 (6%) 0.408 23 (20%) 5 (12%) 0.347
CAD/prior MI 36 (16%) 20 (19%) 0.642 17 (17%) 10 (15%) 0.833 18 (16%) 10 (24%) 0.237
Carotid Stenosis 5 (2%) 1 (1%) 0.668 2 (2%) 0 (0%) 0.519 3 (3%) 1 (2%) >.99
Dyslipidemia 100 (46%) 44 (41%) 0.410 46 (46%) 25 (38%) 0.342 53 (46%) 19 (46%) >.99
Hypertension 171 (78%) 87 (81%) 0.667 86 (85%) 55 (83%) 0.828 83 (72%) 32 (78%) 0.539
Previous Stroke 61 (28%) 23 (21%) 0.227 29 (29%) 13 (20%) 0.207 32 (28%) 10 (24%) 0.838
Previous TIA 13 (6%) 5 (5%) 0.798 5 (5%) 2 (3%) 0.705 8 (7%) 3 (7%) >.99
Depression 27 (12%) 13 (12%) >.99 12 (12%) 6 (9%) 0.620 15 (13%) 7 (17%) 0.601
Heart Failure 24 (11%) 7 (6%) 0.232 12 (12%) 6 (9%) 0.620 11 (9%) 1 (2%) 0.187
Obesity/
Overweight
140 (64%) 63 (58%) 0.335 66 (65%) 40 (61%) 0.622 73 (63%) 22 (54%) 0.354
Smoker 58 (26%) 34 (31%) 0.362 36 (36%) 23 (35%) >.99 22 (19%) 11 (27%) 0.372
Family History
of Stroke
29 (13%) 14 (13%) >.99 14 (14%) 8 (12%) 0.818 15 (13%) 6 (15%) 0.792
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Table 2 (Continued)
Variable Response Total African American Non-African American
2019 (N= 219) 2020 (N= 108) p-value 2019 (N= 101) 2020 (N= 66) p-value 2019 (N= 116) 2020 (N= 41) p-value
Sleep Apnea 14 (6%) 6 (6%) >.99 8 (8%) 3 (5%) 0.530 6 (5%) 3 (7%) 0.698
DVT/PE 4 (2%) 6 (6%) 0.087 1 (1%) 3 (5%) 0.302 3 (3%) 3 (7%) 0.184
Drugs/Alcohol
Abuse
16 (7%) 14 (13%) 0.106 8 (8%) 10 (15%) 0.201 8 (7%) 4 (10%) 0.513
In-hospital information




57 (26%) 19 (18%) 0.095 13 (13%) 11 (17%) 0.507 43 (38%) 8 (20%) 0.035
Emergency Depart-
ment/Urgent Care
160 (74%) 89 (82%) 88 (87%) 55 (83%) 71 (62%) 33 (80%)
Method of Arrival EMS from home/
scene




66 (30%) 23 (21%) 38 (38%) 16 (24%) 28 (24%) 7 (17%)
Transfer from other
hospital
91 (42%) 30 (28%) 23 (23%) 14 (21%) 66 (57%) 16 (39%)
NIHSS at
Admission
N Median (IQR) 195 3 (1, 6) 91 5 (3, 10) 0.002 92 3 (1, 6) 53 5 (3, 10) 0.005 102 2 (0, 7) 37 5 (1, 11) 0.165
Stroke type ICH/SAH 29 (13%) 23 (21%) 0.076 12 (12%) 18 (27%) 0.014 15 (13%) 5 (12%) >.99
AIS/TIA 190 (87%) 85 (79%) 89 (88%) 48 (73%) 101 (87%) 36 (88%)
AIS Etiology Large-artery
atherosclerosis
33 (20%) 22 (28%) 0.216 14 (18%) 12 (27%) 0.303 19 (22%) 10 (31%) 0.585
Cardio-embolism 40 (24%) 18 (23%) 18 (23%) 9 (20%) 22 (25%) 9 (28%)
Small-vessel
disease




1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 0 (0%)
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Table 2 (Continued)
Variable Response Total African American Non-African American





N Median (IQR) 47 14
(9, 23)
17 8 (7, 14) 0.049 34 14.5
(9, 23)





N Median (IQR) 116 14
(6.5, 23)
77 13 (5, 23) 0.122 76 14.5
(4.5, 66)
52 17 (9, 30) 0.608 40 13.5 (7, 31) 24 6.5
(1.5, 15.1)
0.015
CT Perfusion 36 (16%) 21 (19%) 0.536 20 (20%) 14 (21%) 0.846 16 (14%) 7 (17%) 0.613
DSA 5 (2%) 6 (6%) 0.188 1 (1%) 1 (2%) >.99 4 (3%) 5 (12%) 0.053
CTA 101 (46%) 59 (55%) 0.159 58 (57%) 37 (56%) 0.874 43 (37%) 21 (51%) 0.140





N Median (IQR) 137 2 (0, 3) 53 3 (1, 6) 0.004 741 (0, 3) 36 3.5 (2, 7) <.001 63 2 (0, 3) 17 1 (0, 5) 0.538
mRS at Discharge
(0-2 vs 3-5 vs
died) for AIS and
TIA patients
02 (Favorable) 109 (59%) 41 (50%) 0.1542 55 (64%) 23 (49%) 0.173 54 (55%) 17 (50%) 0.036
35 (Unfavorable) 71 (39%) 36 (44%) 28 (33%) 23 (49%) 43 (44%) 13 (38%)
Died 4 (2%) 5 (6%) 3 (3%) 1 (2%) 1 (1%) 4 (12%)
Length of stay
(Hours)













Disposition Home 130 (59%) 56 (52%) 0.0553 60 (59%) 31 (47%) 0.329 69 (59%) 24 (59%) 0.087
Hospice - Home 2 (1%) 4 (4%) 1 (1%) 3 (5%) 1 (1%) 1 (2%)
Hospice - Health
Care Facility
4 (2%) 0 (0%) 0 (0%) 0 (0%) 4 (3%) 0 (0%)
Acute Care Facility 2 (1%) 0 (0%) 1 (1%) 0 (0%) 1 (1%) 0 (0%)
Other Health Care
Facility
69 (32%) 36 (33%) 33 (33%) 26 (39%) 36 (31%) 10 (24%)
Expired 8 (4%) 11 (10%) 4 (4%) 5 (8%) 3 (3%) 6 (15%)
Left AMA 4 (2%) 1 (1%) 2 (2%) 1 (2%) 2 (2%) 0 (0%)
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Discussion
In the US, Michigan experienced the first surge of
COVID-19 cases in the early days of the pandemic, from
March 10 to May 2020.11 Wayne County (Detroit)
accounted for most of the cases in the state and was in the
top 5 most affected counties early in the pandemic.12,13
HFHS and its 6 hospitals across southeast and central
Michigan adopted a system-wide amendment of its Emer-
gency Care and Admission of patients with AIS/TIA policy.
The policy addressed the following key points: (1)
increase the response to stroke alerts via telephone or
video consults, (2) limit the number of transfers from out-
side facilities, (3) provide guidance for the management
and triaging of patients with AIS/TIA for safe discharge
from the ED, and (4) intubate all patients requiring MT in
an effort to reduce the risk of aerosolization. The policy
went into effect on March 20 and was still active on May
20, last day of patient inclusion into the study.
Our study echoes several others’ findings linked to the
pandemic’s impact on AIS/TIA and ICH/SAH care. First,
consistent with prior reports,14 we found that the rates of
STA in our EDs dramatically decreased during the pan-
demic by 54%. Reports around the world vary in the mag-
nitude of this effect based on geographical location and
timing of reporting: 940% in France,9,15 2328% in
Spain,4 2431% in Scandinavia,16 25% in California,17
32% in neighboring Ontario (Canada),18 40% in China,5,14
and 3046% in New York.19 These observations are a
direct consequence of the implementation of stay-at-home
orders and lockdowns enforced by local and federal gov-
ernments.20 Compared to New England which experi-
enced the surge in COVID-19 cases at around the same
time as Michigan, our health system, however, registered
much higher declines in stroke presentations and admis-
sions for reasons that are not entirely clear. Second, trans-
fers from outside facilities into HFHS were found to be
significantly reduced, congruent with the tier 1 policy
delineated above and in line with other reports. Similarly,
both IVT and MT rates declined during the COVID-19
period, as has been previously described.20-22
While confirming previously reported findings, our study
distinguishes itself in the fact that our health system serves a
large AA population. For instance, while we found that times
from LKW to ED presentation were significantly increased
during the pandemic, when dichotomized on the basis of
race, this finding held true only for AAs (10.4 vs 5.2 h). In
fact, delayed presentation was more frequently a reason to
exclude AAs than other groups from receiving IVT in 2020.
Nonetheless, the rate of IVT administration did not differ
between the two groups in 2020. The only other report we
found in the literature addressing racial disparity in stroke
presentation during the pandemic is a study out of South
Carolina that reported lower rates of AAs seeking medical
care for AIS compared to the prior year (13.9% vs 29%,






























































































































































































































































































































































































































10 H. ABOUL NOUR ET AL.
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by 
Elsevier on April 23, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Table 3. IVT and MT information.
Variable Response Total African American Non-African American
2019 2020 p-value 2019 2020 p-value 2019 2020 p-value
IVT information for eligible patients (African American n=125 with 78 in 2019 and 47 in 2020; Non-African American=121 with 89 in 2019 and 32 in 2020)
IVT given at HFH Yes 17 (12%) 13 (20%) 0.143 12 (17%) 7 (16%) >.99 5 (7%) 5 (23%) 0.048
No1 126 (88%) 53 (80%) 58 (83%) 36 (84%) 68 (93%) 17 (77%)
IVT given at HFH
or outside HFH
Yes 26 (17%) 19 (26%) 0.112 16 (22%) 9 (20%) >.99 10 (13%) 9 (35%) 0.019





15 (11%) 8 (13%) 0.075 4 (6%) 2 (5%) 0.626 11 (14%) 6 (26%) 0.106
Rapid
improvement
10 (7%) 0 (0%) 3 (5%) 0 (0%) 7 (9%) 0 (0%)
Delay in patient
arrival
108 (77%) 52 (85%) 51 (82%) 36 (95%) 57 (72%) 16 (70%)
Stroke severity
too mild





1 (1%) 1 (2%) 1 (2%) 0 (0%) 0 (0%) 1 (4%)
Patient/family
refused





















5 2 (2, 2.9) 0.324
MT information for eligible patients (African American=28 with 17 in 2019 and 11 in 2020; Non-African American=40 with 25 in 2019 and 15 in 2020)
MT received Yes 16 (38%) 14 (52%) 0.323 6 (35%) 3 (27%) >.99 10 (40%) 11 (73%) 0.055
No 26 (62%) 13 (48%) 11 (65%) 8 (73%) 15 (60%) 4 (27%)
Reasons for not
receiving MT6
NIHSS<6 12 (29%) 7 (26%) 0.821 5 (45%) 4 (50%) 0.592 7 (47%) 2 (50%) >0.99
Established
Stroke
5 (12%) 3 (11%) 1 (9%) 2 (25%) 4 (27%) 1 (25%)
Other reason for
no MT7
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(i.e., the percentage of AAs presenting for stroke symptoms to
the ED pre-COVID and during the pandemic were the same),
it does however show that AAs had on average higher
NIHSS on admission and discharge during the pandemic
compared to the year prior. A likely explanation for this find-
ing is that AAs were either reluctant to seek medical attention
early but eventually did when symptoms were not improv-
ing, or patients were more frequently by themselves and
unattended due to the observation of social distancing. This
may have contributed to the poorer outcomes of AAs com-
pared to other groups in 2020. This disparity can find its root
in the fact that, early in the pandemic, it becamewidely recog-
nized that AAs were disproportionately more vulnerable to
COVID-19’s complications and endured higher mortality
rates than other races, presumably due to more severe comor-
bidities, lower socioeconomic status, and decreased access to
healthcare.24-26
Despite the longer times to ED arrival in 2020, metrics
related to processes occurring within the ED, such as times
from arrival to STA, were remarkably improved and had
no racial differential. Additionally, average DTN for IVT
administration was faster, particularly among AAs (38 vs
58.5 min), despite the requirement to don and doff PPE for
all patients, regardless of their COVID-19 status. Similarly
and perhaps counterintuitively, the requirement to intubate
all patients undergoing MT during the pandemic did not
appear to lengthen the door-to-arterial puncture time. This
is in stark contrast with previous data reporting either no
significant difference or longer treatment times for either or
both IVT and MT.27-29 Taken together, these findings illus-
trate the greater efficiency of our ED, stroke, neurointerven-
tional and anesthesia teams in triaging and managing AIS
during the pandemic. This can be explained in part by the
unusually small numbers of stroke patients presenting to
two busy centers that ordinarily manage multiple stroke
codes simultaneously. A likely explanation is the signifi-
cantly lower rates of stroke mimics (17% vs 37%) and
minor/rapidly improving strokes seen during the pan-
demic (0% vs 7%), thereby offloading the ED. The reluc-
tance of patients to seek care in EDs for mild
symptomatology during COVID has been described in
prior studies.16 It is worth adding that the lower incidence
of stroke mimics may account for the artificially increased
rates of other diagnoses such as AIS, ICH and SAH in 2020.
Our study has several limitations. First, a number of data
points could not be obtained from charts, thereby poten-
tially diluting the effects of race and time period on some
of the variables such as time metrics, NIHSS or mRS. Most
of the unavailable data comes from incomplete records
from outside facilities transferring patients to our hospitals.
We believe that additional and more robust associations
may have been possible had the dataset been more com-
plete. Second, reasons for delayed presentations to the hos-
pital were usually not documented, making them subject
to interpretation. We believe, however, that these interpre-
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comparison periods (COVID and Pre-COVID periods) did
not allow us to account for the temporal trends over a year.
Fourth, our data is confined to a single, albeit large, health
system in Southeast Michigan and may therefore not be
representative of other areas across the state or the country,
limiting therefore the generalizability of our data. Nonethe-
less, we believe that the large AA population the data is
derived from can be utilized to understand the impact of
the pandemic on stroke care in other large urban areas
across the US with a similar racial and ethnic makeup.
Fifth, we chose not to include teleneurology data since this
novel technology was only rolled out during the pandemic
and did not make up a significant proportion of stroke
code evaluations. We also decided not to include in-house
SAs in our analysis in order not to introduce bias since we
only keep records of those SAs that result in true ischemic
or hemorrhagic strokes. Lastly, although we found a statis-
tically significant increase in mortality in non-AAs between
2019 and 2020 (1% vs 12%, p =0.036), we believe that this
increase was unlikely to be related to COVID-19 since only
one patient of those who died in 2020 tested positive for
the virus. The cause for this observation remains unclear to
us. The small sample size may have played a role and sta-
tistical significance may not hold in a larger sample.
Assessing data from outpatient visits of patients whose
strokes occurred during the pandemic but chose not to
seek medical attention at the time, understanding the rea-
sons that motivated patients to not seek care early, and
expanding data collection to other centers in the area
would be useful to refine our understanding of the multi-
layered impact COVID-19 has had on our specific stroke
patient population. This knowledge may be instrumental
in preparing for future waves of COVID-19 infections.
Conclusion
Our study demonstrates that the COVID-19 pandemic
has caused a reduction in the number of patients seeking
medical attention for stroke symptoms and in those receiv-
ing acute therapies such as IVT and MT. It has also resulted
in fewer stroke mimics and minor/rapidly improving
strokes presenting to the ED. Furthermore, ED processes
were markedly improved during the pandemic such as time
from patient arrival to stroke code activation, imaging and
IVT but it did not significantly alter MT metrics. Finally,
among our predominantly AA population, patients’ ED pre-
sentation was significantly delayed. They also had more
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